Gregory Licholai
Chief Tech/Sci/R&D Officer bei ICON PUBLIC LIMITED COMPANY
Profil
Gregory P. Licholai, Gründer von Immunome, Inc., ist derzeit Chief Medical & Innovation Officer bei ICON plc und Präsident von Elpidera LLC. Dr. Licholai ist auch Mitglied des Vorstands von Sollis Therapeutics, Inc. Zuvor war er President & Chief Scientific Officer bei Castle Creek Pharmaceuticals LLC, Vice President-Medical Affairs bei Amicus Therapeutics, Inc. sowie Director-Ventures & Business Associates bei Medtronic Neurological und Director bei Immunome, Inc. Gregory P. Licholai erwarb einen Bachelor-Abschluss am Boston College, einen Doktortitel an der Yale University und einen MBA an der Harvard University.
Aktive Positionen von Gregory Licholai
| Unternehmen | Position | Beginn |
|---|---|---|
| ICON PUBLIC LIMITED COMPANY | Chief Tech/Sci/R&D Officer | 01.11.2021 |
| Elpidera LLC | President | - |
Ehemalige bekannte Positionen von Gregory Licholai
| Unternehmen | Position | Ende |
|---|---|---|
Castle Creek Biosciences, Inc.
 Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Castle Creek Biosciences, Inc. engages in the research and development of gene therapies for patients with rare and genetic diseases. It offers treatment for Recessive Dystrophic Epidermolysis Bullosa (RDEB) and localized Scleroderma; and topical ointment for Epidermolysis Bullosa Simplex. The company was founded by Jeffrey S. Aronin in September 2018 and is headquartered in Exton, PA. | President | 01.02.2018 |
| AMICUS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 02.10.2009 |
| Medtronic Neurological | Corporate Officer/Principal | 01.11.2002 |
| MODERNA, INC. | Corporate Officer/Principal | - |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Ausbildung von Gregory Licholai
| The Trustees of Columbia University in The City of New York | Undergraduate Degree |
| Boston College | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
| Yale School of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| ICON PUBLIC LIMITED COMPANY | Commercial Services |
| AMICUS THERAPEUTICS, INC. | Health Technology |
| IMMUNOME, INC. | Health Technology |
| MODERNA, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Commercial Services |
| Medtronic Neurological | |
| Elpidera LLC | |
Castle Creek Biosciences, Inc.
Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Castle Creek Biosciences, Inc. engages in the research and development of gene therapies for patients with rare and genetic diseases. It offers treatment for Recessive Dystrophic Epidermolysis Bullosa (RDEB) and localized Scleroderma; and topical ointment for Epidermolysis Bullosa Simplex. The company was founded by Jeffrey S. Aronin in September 2018 and is headquartered in Exton, PA. | Health Technology |
